[
    [
        {
            "time": "",
            "orginal_text": "白云山(600332.SH)：医药公司拟通过增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
            "features": {
                "keywords": [
                    "白云山",
                    "医药公司",
                    "增资扩股",
                    "战略合作伙伴",
                    "管理层",
                    "核心骨干员工持股"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "白云山(600332.SH)：医药公司拟通过增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
            "scores": {
                "News_content": "白云山(600332.SH)：医药公司拟通过增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "广州医药上市，最新进展公布",
            "features": {
                "keywords": [
                    "广州医药",
                    "上市",
                    "最新进展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "广州医药上市，最新进展公布",
            "scores": {
                "News_content": "广州医药上市，最新进展公布",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "orginal_text": "白云山(00874.HK)：广州医药拟增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
            "features": {
                "keywords": [
                    "白云山",
                    "广州医药",
                    "增资扩股",
                    "战略合作伙伴",
                    "管理层",
                    "核心骨干员工持股"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "original_text": "白云山(00874.HK)：广州医药拟增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
            "scores": {
                "News_content": "白云山(00874.HK)：广州医药拟增资扩股引入战略合作伙伴及对管理层及核心骨干员工持股",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "orginal_text": "白云山：拟对广州医药增资扩股不高于9.6亿元",
            "features": {
                "keywords": [
                    "白云山",
                    "广州医药",
                    "增资扩股",
                    "9.6亿元"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "白云山：拟对广州医药增资扩股不高于9.6亿元",
            "scores": {
                "News_content": "白云山：拟对广州医药增资扩股不高于9.6亿元",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]